Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triple versus quadruple therapy for H. pylori-related chronic gastritis
ChiCTR-IPR-16009411Phase 4Completed
- Sponsor
- Institute of Gastroenterology, Zhejiang University
- Start
- May 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of proton pump inhibitor + bismuth subsalicylate + metronidazole + tetracycline in Helicobacter pylori infection and chronic gastritis (2 arms), sponsored by Institute of Gastroenterology, Zhejiang University. Primary endpoint: H. pylori eradication rates. Started May 2011; status: completed.
02
Drugs
proton pump inhibitor + bismuth subsalicylate + metronidazole + tetracycline
03
Conditions
Helicobacter pylori infectionchronic gastritis
Beyond the preview
Go deeper on ChiCTR-IPR-16009411.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-16009411.